Organon & Co. is a public company listed on the NYSE with a current market cap of 66.2 billion USD. Looking at their Revenue record for the last 5 quarters, we can gain insight into their financial situation.
The most recent quarter reported was on February 17th 2022 with an EPS of 1.37 and revenue of 16 bln USD. The quarter before that, reported on May 5th 2022 showed an even higher EPS of 1.65 and revenue of 15.7 bln USD, both representing an increase from the previous reporting periods.
In addition to increasing profits from quarter to quarter, Organon & Co.’s stock has performed well over the past year - with a share price currently hovering at 26.02 USD, compared to a low of 22.88 in early 2021 and a high of 39.47 USD in mid-2021 - representing a cumulative increase of nearly 15%.
Overall, this data suggests that Organon & Co.’s financial situation is healthy and growing, with increasing profits and rising share prices over the past year demonstrating investor confidence in their performance going forward
